Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5776885 | VERITY | Sustained and controlled release of water insoluble polypeptides |
Jul, 2015
(8 years ago) | |
US10166181 | VERITY | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(5 years from now) |
Trelstar is owned by Verity.
Trelstar contains Triptorelin Pamoate.
Trelstar has a total of 2 drug patents out of which 1 drug patent has expired.
Expired drug patents of Trelstar are:
Trelstar was authorised for market use on 29 June, 2001.
Trelstar is available in injectable;intramuscular dosage forms.
The generics of Trelstar are possible to be released after 30 June, 2029.
Drugs and Companies using TRIPTORELIN PAMOATE ingredient
Market Authorisation Date: 29 June, 2001
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR